QTTB compared with IMA: revenue, margins and what each company keeps, and the suppliers and customers both name

QTTBQ32 Bio Inc.

Mkt capRevenueRevenue

IMAImageneBio, Inc.

Mkt capRevenueRevenue

Compare

QTTBQ32 Bio Inc.

IMAImageneBio, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

QTTB1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.2%▲+2.07%×0.13

IMA1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+0.70%—

= impliedQTTB realized, solidIMA realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

QTTBQ32 Bio Inc.

8.68· pre 8.70· delayed

Mkt cap$259.3MRevenue$54MQ4 FY25

IMAImageneBio, Inc.

4.10· pre 4.10· delayed

Pre-marketNov 3 '26delayed

Mkt cap$46.5MRevenue$800,000Q4 FY25

Compare

Pre-marketNov 3 '26delayed

QTTBQ32 Bio Inc.

IMAImageneBio, Inc.

8.68pre 8.70delayed

Price

4.10pre 4.10delayed

$259.3M

Mkt cap

$46.5M

Q4 FY25$54M

Revenue

$800,000Q4 FY25

QTTB8.68vsIMA4.10Pre-marketNov 3 '26delayed